30 Day Trial

About ORTHOWORLD

Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.

ORTHOFLASH Subscribe

07/21/2017
  • 1:30 p.m. Tissue Regenix proposes to acquire CellRight Technologies for US $30MM, to offer products for bone and soft tissue regeneration.
  • Paragon 28 launched the Proximal Rotational Metatarsal Osteotomy Triplanar Hallux Valgus Correction system.
  • ORTHOWORLD estimates DePuy Synthes’ 2Q17 orthopaedic revenue at US $2,214.8MM, +0.4% vs. 2Q16.
Read More

Articles of Interest All Articles

Orthopaedic Product Launches from Top 4 Device Companies at Close of 2Q17

The top four orthopaedic device manufacturers—DePuy Synthes, Zimmer Biomet, Stryker and Smith & Nephew—ended the last week of 2Q17 with product launches.